SAPA-NE 2022 Bimonthly Workshop- Technology Trends

Developing Microbes as Drugs: Opportunities  & Challenges

Content

Microorganisms have already proven that they can function as powerful medicine factories. Many drugs are developed from primary and secondary metabolites of numerous organisms such as plants, animals, and microbes. In 1997, 42% of the best-selling pharmaceutical drugs were derived from microbial metabolites. Combining with the fact that microbes are integral part of the body, in recent years, microbes themselves have been explored for their untapped therapeutic potential. Come to hear from the industry expert on the opportunities and challenges while developing microbes as drugs.

Speaker

Bharat Dixit, Chief Technology Officer at AdisoTherapeutics

Bharat Dixit is the Chief Technology Officer at Adiso Therapeutics. He has more than fifteen years of experience in the biotechnology industry with a focus in the area of life biotherapeutics for last several years. Over the years he has led bioprocess and analytical development, drug formulation including fill-finish and cGMP manufacturing. Prior to joining Adiso, he led process and product development teams at ArtugenTherapeutics, Finch Therapeutics, and Crestovo in the microbiome space.